November 25, 2015November 25, 2015

AstraZeneca Sells US Rights over Gastroenterological Drug Entocort (Budesonide)

News

AstraZeneca recently announced an agreement with Perrigo Company plc regarding the divestment of rights for Entocort® (budesonide) in the United States. Entocort is a locally-acting glucocorticosteroid considered a first-line therapy indicated for ... Read more

July 9, 2015September 28, 2016

Tillotts Pharma AG To Acquire Global Rights for Entocort (budesonide) Outside The U.S. Under Agreement With AstraZeneca

Crohn's Disease, News

Rheinfelden, Switzerland based Tillotts Pharma AG (“Tillotts”), part of Japan’s Zeria Group, has announced its entry into an agreement in which it will acquire global rights from London based AstraZeneca ... Read more